|
1. BIOLOGIE
|
|
|
|
|
1.1 BIOLOGIE - GÉNOME
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
4.1 DÉP., DIAG. & PRONO. - PROSTATE
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
A personalized CAR-T to attack every solid tumor? Pact Pharma has a plan [Fierce Biotech]
|
|
|
|
|
|
The process starts by using bioinformatics technology to identify the “mutation blueprint” of each patient’s tumor, according to a statement. From there, Pact’s scientists can capture T cells in the blood that already have the ability to recognize and target those mutations. The researchers then identify mutation-targeted T-cell receptors and use gene editing to attach them to T cells from the patients.
|
|
|
|
|
|
|
|
5.16 TRAITEMENTS - CHIRURGIE
|
|
|
|
|
5.2.1 PHARMA - PARTENARIATS
|
|
|
AstraZeneca spearheads lung cancer alliance aiming to boost survival rates [Fierce Pharma]
|
|
|
|
|
|
Aside from the British drugmaker, the group is made up of a global physicians' group (International Association for the Study of Lung Cancer), patients and patient advocates (Global Lung Cancer Coalition) and a diagnostic company (Guardant Health), making it a diverse group but one with specific goals. It already has four projects underway to address a variety of issues in lung cancer.
|
|
|
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
|
6.1 OBSERVATION
|
|
|
|
|
6.8 COMMUNICATION
|
|
|